Who is sponsoring NCT00805688?

NCT00805688 is sponsored by M.D. Anderson Cancer Center.

What condition does NCT00805688 study?

NCT00805688 studies Pancreatic Cancer.

What drugs are being tested in NCT00805688?

Interventions: Questionnaires, Blood Draws, Pedometer.

What is the status of NCT00805688?

NCT00805688 is currently COMPLETED.

Last reviewed 2018-03-06 · How we verify

Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer

NCT00805688 COMPLETED

The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experience. The study will also use a special telephone system for measuring the symptoms of participants during and after therapy. Your level of physical activity will also be studied using a pedometer and study diary.

Details

Lead sponsor	M.D. Anderson Cancer Center
Status	COMPLETED
Enrolment	100
Start date	Wed Nov 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Pancreatic Cancer

Interventions

Questionnaires
Blood Draws
Pedometer

Countries

United States